Oncocyte to Release First Quarter 2025 Results on May 12, 2025
Oncocyte (Nasdaq: OCX), a diagnostics technology company, has scheduled its first quarter 2025 financial results announcement for May 12, 2025, after market close. The company will host a live Zoom webinar at 2:00 p.m. PT on the same day to discuss the results, followed by a Q&A session. Interested participants can access the webinar through registration, and a replay will be available on Oncocyte's investor relations website afterward.
Oncocyte (Nasdaq: OCX), azienda nel settore delle tecnologie diagnostiche, ha programmato la comunicazione dei risultati finanziari del primo trimestre 2025 per il 12 maggio 2025, dopo la chiusura del mercato. La società terrà un webinar live su Zoom alle 14:00 PT dello stesso giorno per discutere i risultati, seguito da una sessione di domande e risposte. Gli interessati possono partecipare registrandosi al webinar, e la registrazione sarà disponibile successivamente sul sito web delle relazioni con gli investitori di Oncocyte.
Oncocyte (Nasdaq: OCX), una empresa de tecnología diagnóstica, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 12 de mayo de 2025, después del cierre del mercado. La compañía realizará un seminario web en vivo por Zoom a las 2:00 p.m. PT del mismo día para discutir los resultados, seguido de una sesión de preguntas y respuestas. Los interesados pueden acceder al seminario web mediante registro, y una repetición estará disponible posteriormente en el sitio web de relaciones con inversores de Oncocyte.
Oncocyte(나스닥: OCX) 진단 기술 회사는 2025년 1분기 재무 실적 발표를 2025년 5월 12일 시장 마감 후에 예정했습니다. 회사는 같은 날 오후 2시(태평양 시간)에 Zoom 라이브 웨비나를 개최하여 실적을 논의하고, 이어서 질의응답 시간을 가질 예정입니다. 관심 있는 참가자는 등록을 통해 웨비나에 참여할 수 있으며, 이후 Oncocyte 투자자 관계 웹사이트에서 다시보기 영상을 제공할 예정입니다.
Oncocyte (Nasdaq : OCX), une entreprise de technologie diagnostique, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 12 mai 2025, après la clôture du marché. La société organisera un webinaire en direct sur Zoom à 14h00 PT le même jour pour discuter des résultats, suivi d'une session de questions-réponses. Les participants intéressés peuvent accéder au webinaire en s'inscrivant, et une rediffusion sera disponible par la suite sur le site des relations investisseurs d'Oncocyte.
Oncocyte (Nasdaq: OCX), ein Unternehmen für Diagnosetechnologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 12. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 14:00 Uhr PT ein Live-Zoom-Webinar veranstalten, um die Ergebnisse zu besprechen, gefolgt von einer Fragerunde. Interessierte Teilnehmer können sich für das Webinar registrieren, und eine Aufzeichnung wird anschließend auf der Investor-Relations-Website von Oncocyte verfügbar sein.
- None.
- None.
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results at 2:00 p.m. PT that same day.
The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: Oncocyte Q1 2025 Earnings Webinar.
An archived replay will be available after the call concludes on Oncocyte’s investor relations website at https://investors.oncocyte.com.
About Oncocyte
Oncocyte is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.oncocyte.com/ for more information.
Investor Contact:
Doug Farrell
LifeSci Advisors LLC
dfarrell@lifesciadvisors.com
FAQ
When will Oncocyte (OCX) release Q1 2025 earnings?
What time is Oncocyte's Q1 2025 earnings call?
How can I access Oncocyte's Q1 2025 earnings call?
Where can I find the replay of Oncocyte's Q1 2025 earnings call?
